<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02601898</url>
  </required_header>
  <id_info>
    <org_study_id>ALAvsPROG</org_study_id>
    <nct_id>NCT02601898</nct_id>
  </id_info>
  <brief_title>Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment</brief_title>
  <official_title>Vaginal Administration of Alpha Lipoic Acid vs Progesterone for the Subchorionic Hematoma Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda USL Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda USL Ferrara</source>
  <brief_summary>
    <textblock>
      The aim of this study was to compare the therapeutic efficacy of lipoic acid versus
      progesterone by vaginal administration on subchorionic hematoma resorption in women at the
      first trimester of pregnancy with threatened miscarriage.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in subchorionic hematoma from baseline at 20 days and 40 days, assessed as %improvement/worsening by ultrasoud examination</measure>
    <time_frame>T1 (20 days); T2 (40 days)</time_frame>
    <description>The evaluation of the hematoma significance is done comparing its size with that one of the gestational sac during the ultrasound examination. Changes in hematoma resorption (% improvement/ worsening) during the treatment were obtained for each patient by calculating the Î” percentage between two subsequent time points.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with abdominal pain as assessed by questionnaire</measure>
    <time_frame>T1 (20 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with vaginal bleeding as assessed by questionnaire</measure>
    <time_frame>T1 (20 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with abdominal pain as assessed by questionnaire</measure>
    <time_frame>T2 (40 days)</time_frame>
    <description>Questionaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with vaginal bleeding as assessed by questionnaire</measure>
    <time_frame>T2 (40 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who miscarried as assessed by ultrosound examination</measure>
    <time_frame>20 weeks of gestation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Subchorionic Hematoma in the First Trimester Pregnancy</condition>
  <condition>Miscarriage</condition>
  <arm_group>
    <arm_group_label>Lipoic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>vaginal capsules of lipoic acid (10 mg, one capsule per day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Progesterone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Vaginal soft gel of progesterone (200 mg, two capsules per day)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Lipoic acid</intervention_name>
    <description>Vaginal capsules (medical device) containing 10 mg of lipoic acid (1 per day)</description>
    <arm_group_label>Lipoic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Progesterone</intervention_name>
    <description>Vaginal capsules (drug) containing 200 mg of progesterone (2 per day)</description>
    <arm_group_label>Progesterone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: 24-37

          -  Gestational week: 7- 12

          -  Evidence of threatened miscarriage (pelvic pain with or without vaginal bleeding)

          -  Ultrasound evidence of subchorionic hematoma

        Exclusion Criteria:

          -  Lack of fetus

          -  Absence of fetal heart tone

          -  Uterine anomaly or fetal anomaly

          -  Presence of multiple pregnancy

          -  Gestation pathology

          -  Therapies with anti-coagulants or anti-hypertensive drugs
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>37 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Azienda USL Ferrara</name>
      <address>
        <city>Ferrara</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Yassaee F, Shekarriz-Foumani R, Afsari S, Fallahian M. The effect of progesterone suppositories on threatened abortion: a randomized clinical trial. J Reprod Infertil. 2014 Jul;15(3):147-51.</citation>
    <PMID>25202672</PMID>
  </reference>
  <reference>
    <citation>Porcaro G, Brillo E, Giardina I, Di Iorio R. Alpha Lipoic Acid (ALA) effects on subchorionic hematoma: preliminary clinical results. Eur Rev Med Pharmacol Sci. 2015 Sep;19(18):3426-32.</citation>
    <PMID>26439038</PMID>
  </reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2015</study_first_submitted>
  <study_first_submitted_qc>November 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2015</study_first_posted>
  <last_update_submitted>January 7, 2016</last_update_submitted>
  <last_update_submitted_qc>January 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda USL Ferrara</investigator_affiliation>
    <investigator_full_name>Demetrio Costantino</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematoma</mesh_term>
    <mesh_term>Abortion, Spontaneous</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Progesterone</mesh_term>
    <mesh_term>Thioctic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

